Amneal Pharmaceuticals (AMRX) Goodwill (2017 - 2026)

Amneal Pharmaceuticals has reported Goodwill for 10 years, with the latest figure at $593.5 million in Q2 2026.

• On a quarterly basis, Goodwill fell 0.65% year-over-year to $593.5 million in Q2 2026; TTM through Jun 2026 was $593.5 million, a 0.65% decrease from a year earlier, with the FY2025 full-year figure at $595.5 million, changed 0.33% from the prior year.
• Goodwill was $593.5 million for Q2 2026 at Amneal Pharmaceuticals, roughly flat from $593.8 million in the prior quarter.
• The five-year high for Goodwill was $602.9 million in Q1 2022, with the low at $593.5 million in Q2 2026.
• Average Goodwill over 5 years is $598.0 million, with a median of $598.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Goodwill gained 15.33% in 2022, then retreated 0.65% in 2026.
• Over 5 years, Goodwill stood at $598.9 million in 2022, then retreated by 0.04% to $598.6 million in 2023, then slipped by 0.2% to $597.4 million in 2024, then declined by 0.33% to $595.5 million in 2025, then declined by 0.33% to $593.5 million in 2026.
• The last three Goodwill figures came in at $593.5 million (Q2 2026), $593.8 million (Q1 2026), and $595.5 million (Q4 2025), per Business Quant data.